News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Adeza Biomedical (ADZA) Announces August 29 FDA Advisory Committee Date To Review Gestiva To Prevent Preterm Births



7/18/2006 2:11:11 PM

SUNNYVALE, Calif.--(BUSINESS WIRE)--July 18, 2006--Adeza (NASDAQ:ADZA - News) today announced that its New Drug Application (NDA) for Gestiva(TM) will be reviewed by the Reproductive Health Drugs Advisory Committee to the U.S. Food and Drug Administration (FDA) on August 29, 2006. Gestiva, a long acting form of a naturally occurring progesterone, is the company's drug candidate to prevent preterm birth in women with a history of preterm delivery.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES